InterVene Raises $15 Million in Series B funding for catheter-based deep venous reflux treatment
InterVene has announced it has raised US$15 million in a Series B financing round. The company’s BlueLeaf Endovenous Valve Formation System is the first catheter-based solution...
New West London Vascular and Interventional Centre opens, highlighting the importance of specialty centralisation
The new West London Vascular and Interventional Centre at Northwick Park Hospital (Harrow, UK) has officially been declared open. As of the 25th June,...
Mentice and Siemens Healthineers bring a virtual patient to the angiosuite
Siemens Healthineers and Mentice AB have announced that they are collaborating to fully integrate Mentice’s VIST virtual patient into the Artis icono angiography system...
Catheter-directed thrombolysis treatment for PE may significantly reduce long-term costs with better outcomes
Catheter-directed thrombolysis improves outcomes and long-term cost efficiency for treatment of massive and submassive pulmonary embolism (PE), in comparison to systemic heparin administration. This...
(Visited 4,470 times, 9 visits today)
